Keyphrases
Colon Cancer Cells
100%
Aldose Reductase Inhibitor
100%
Cardiotoxicity
100%
Doxorubicin
100%
Doxorubicin Sensitivity
100%
Fidarestat
80%
Colorectal Cancer Cells
60%
Multidrug Resistance Protein 1 (MDR1)
40%
Cancer Growth
20%
Colorectal Cancer
20%
Cardiac Function
20%
High Dose
20%
HT-29
20%
Adjuvant Therapy
20%
In Cancer
20%
Drug Transporters
20%
Inflammatory Markers
20%
Nude Mice Xenograft
20%
Effective Compounds
20%
Anthracycline Antibiotics
20%
Growth in Vitro
20%
Troponin
20%
Anthracyclines
20%
Cancer Therapy
20%
Intracellular Accumulation
20%
SW480 Cells
20%
ABCG2
20%
Daunorubicin
20%
Pharmacology, Toxicology and Pharmaceutical Science
Aldose Reductase Inhibitor
100%
Doxorubicin
100%
Cardiotoxicity
100%
Colon Carcinoma
100%
Colorectal Carcinoma
57%
Fidarestat
57%
Anthracycline
28%
Malignant Neoplasm
14%
Carrier Protein
14%
Cancer Growth
14%
ABCG2
14%
Aldehyde Reductase
14%
Nude Mouse
14%
Troponin I
14%
Daunorubicin
14%
Multidrug Resistance Protein 1
14%
Multidrug Resistance Associated Protein 1
14%
Biochemistry, Genetics and Molecular Biology
Cancer Cell
100%
Colon
100%
Aldose Reductase Inhibitor
100%
Doxorubicin
100%
Anthracycline
28%
Drug Megadose
14%
Aldose Reductase
14%
Nude Mouse
14%
Heart Function
14%
Troponin I
14%
Daunorubicin
14%
ABCG2
14%
Carrier Protein
14%